Mechanism & Scope Fit (molcell-fit)

Why this is skill #1

Molecular Cell triages most submissions to rejection without external review. The gate is not "is it correct" and not "is it interesting" — it is "is the molecular mechanism worked out, proven by independent methods, and shown to matter in a physiological setting." A striking phenotype with a proposed-but-unproven mechanism is desk-rejected. Run this before writing a word.

When to trigger

• Before drafting, to decide if Molecular Cell is the right Cell Press venue.
• When a co-author says "this is a Molecular Cell paper" and you need a sober check.
• When choosing among Molecular Cell, Cell, Cell Reports, and the strong field competitors (NSMB, EMBO J, Genes & Dev, Nucleic Acids Research).

Molecular Cell's home domains

Molecular Cell publishes mechanism in a defined set of areas. Confirm your work sits squarely in one:

• Gene expression — transcription, RNA Pol I/II/III mechanism, splicing, translation.
• Chromatin & epigenetics — nucleosome dynamics, histone modification, remodelers, 3D genome.
• RNA biology — ncRNA, RNA modification, RNP assembly, decay, RNA–protein interactions.
• DNA replication, repair & recombination — replisome, damage response, checkpoint.
• Signaling — molecular logic of a pathway at the level of the modified residue.
• Proteostasis — folding, degradation (UPS, autophagy), stress responses, condensates.
• Protein structure/function — structure used to decide a mechanism, not to describe a fold.

If the work is molecular but has no deep mechanism, or is broad but shallow, reconsider the venue.

The "deep mechanism" test

Molecular Cell wants the how nailed down. Ask:

• Mechanism: do you explain the molecular event (which residue, base, bond, interface, step) — not just the pathway cartoon?
• Orthogonality: do ≥2 independent approaches converge — e.g., biochemistry + structure, genetics + genomics, single-molecule + reconstitution?
• Causality: separation-of-function or point-mutant evidence that ties the mechanism to the phenotype (not just knockout of the whole protein)?
• Physiological relevance: does the mechanism operate in cells/organisms, not only in the tube?
• Reconstitution (where feasible): can you rebuild the activity from defined components?

If mechanism / orthogonality / causality / physiological relevance are not all addressed, it is likely not yet a Molecular Cell paper — name the experiment that closes the gap.

Mechanistic-depth ladder (weak → strong)

1. Reports a phenotype or correlation, mechanism proposed only. (Weak — not Mol. Cell.)
2. Localizes the effect to a protein/complex without the molecular step. (Borderline — Cell Reports.)
3. Defines the molecular mechanism with one strong approach + validation. (Strong — Molecular Cell.)
4. Reconstitutes/visualizes the mechanism with orthogonal biochemistry + structure/single-molecule and separation-of-function mutants. (Strongest — Molecular Cell.)
5. Rewrites the accepted molecular model of a process with decisive, multi-angle evidence. (Cell or Molecular Cell.)

If you cannot place the work at rung 3+ with orthogonal validation, Molecular Cell is a long shot — name the realistic venue honestly.

Fatal pre-review-reject triggers

• Descriptive / correlative — a phenotype or ChIP/RNA-seq correlation with no molecular cause.
• Single technique carrying the whole mechanistic claim.
• Mechanism asserted, not demonstrated — a model cartoon unsupported by point mutants or reconstitution.
• Over-interpreted structure — a coordinate set with functional claims the data don't test.
• No physiological validation — an in-vitro activity never shown to matter in cells/in vivo.
• No reagent/data transparency — undeposited data, unshared constructs, no RRIDs.
• Scope mismatch — broad significance but shallow mechanism → Cell, not Molecular Cell.

Venue routing within Cell Press and beyond

Output format

【Depth rung】 1–5 + one-line justification
【Deep-mechanism test】 mechanism / orthogonality / causality / physiological / reconstitution → which are met
【Domain fit】 which Mol. Cell home domain (or scope mismatch)
【Fatal triggers present】 [...]
【Recommended venue】 Molecular Cell / Cell / Cell Reports / NSMB-EMBO / other
【If staying with Mol. Cell, the one-line mechanistic advance】 "..."
【Gap-closing experiment, if any】 ...
【Next】 molcell-framing (if pass) | reconsider venue (if fail)

Anti-patterns

• Do not mistake a strong phenotype for a mechanism — Molecular Cell wants the molecular step.
• Do not call two runs of the same assay "orthogonal validation."
• Do not confuse a beautiful structure with a tested mechanism.
• Do not let sunk cost drive the venue call; Cell Reports is an honest landing spot.

Confirm scope expectations against the current Molecular Cell information-for-authors page and recent issues.